|
1. |
Australian Institute of Health and Welfare. Australia ’s health 2006. AIHW cat. no. AUS 73. Canberra : AIHW, 2006. |
|
2. |
Price D, Bond C, Bouchard J, et al. International Primary Care Respiratory Group (IPCRG) Guidelines: Management of allergic rhinitis. Prim Care Respir J 2006; 15: 58–70. |
|
3. |
Leynaert B, Bousquet J, Neukirch C, et al. Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: Results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999; 104: 301–4. |
|
4. |
Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108: S147–S334. |
|
5. |
Pedersen PA, Weeke ER. Asthma and allergic rhinitis in the same patients. Allergy 1983; 38: 25–9. |
|
6. |
The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998; 351: 1225–32. |
|
7. |
Guerra S, Sherrill DL, Martinez FD, Barbee RA. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002; 109: 419–425. |
|
8. |
Settipane RJ, Hagy GW, Settipane GA. Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc 1994; 15: 21 –25. |
|
9. |
Leynaert B, Neukirch F, Demoly P, Bousquet J. Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol 2000; 106(5 Suppl): 201–205. |
|
10. |
Thomas M, Kocevar VS, Zhang Q, Yin DD, Price D. Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis. Pediatrics 2005; 115: 129–34. |
|
11. |
Price D, Zhang Q, Kocevar VS, Yin DD, Thomas M. Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults. Clin Exp Allergy 2005; 35: 282–7. |
|
12. |
Fuhlbrigge AL, Adams RJ. The effect of treatment of allergic rhinitis on asthma morbidity, including emergency department visits. Curr Opin Allergy Clin Immunol 2003; 3: 29–32. |
|
13. |
Taramarcaz P, Gibson PG. Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis. Cochrane Database Syst Rev 2003, Issue 3. |
|
14. |
Moller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol. 2002;109: 251–256. |
|
15. |
Novembre E, Galli E, Landi F, et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004; 114: 851–7. |
|
16. |
Robertson CF, Dalton MF, Peat JK, et al. Asthma and other atopic diseases in Australian children. Australian arm of the International Study of Asthma and Allergy in Childhood. Med J Aust 1998; 168: 434–8. |
|
17. |
Robertson CF, Roberts MF, Kappers JH. Asthma prevalence in Melbourne schoolchildren: have we reached the peak? Med J Aust 2004; 180: 273–6. |
|
18. |
Meltzer EO, Hamilos DL, Hadley JA et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004; 114: 155–212. |
|
19. |
Thien F, Raven J, Abramson M. Micronutrients in chronic asthma cohort (1999) data. Personal communication. |
|
20. |
Gøtzsche PC, Johansen HK, Schmidt LM, Burr ML. House dust mite control measures for asthma. Cochrane Database Syst Rev 2004, Issue 4. |
|
21. |
Sheikh A, Hurwitz B. House dust mite avoidance measures for perennial allergic rhinitis: a systematic review of efficacy. Br J Gen Pract 2003; 53: 318–22. |
|
22. |
Brown CL, Graham SM. Nasal irrigations: good or bad? Curr Opin Otolaryngol Head Neck Surg 2004; 12: 9–13. |
|
23. |
Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 1998; 317: 1624–9. |
|
24. |
Lipworth PH, Jackson CM. Safety of inhaled and intranasal
corticosteroids: lessons for the new millennium. Drug Safety 2000 Jul;
23 (1): 11–33. |
|
25. |
Howarth PH. Assessment of antihistamine efficacy and potency. Clin Exp Allergy. 1999; 29 Suppl 3: 87–97. |
|
26. |
Passalacqua G, Canonica GW, Bousquet J. Structure and classification of H1-antihistamines and overview of their activities. Clin Allergy Immunol 2002; 17: 65–100. |
|
27. |
Philip GP, Nayak AS , Berger WE, et al. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin 2004; 20: 1549–58. |
|
28. |
Pharmacy Department, The Royal Women’s Hospital. Drugs and Breastfeeding Handbook. Melbourne : Australia , 2004. |
|
29. |
Fokkens WJ, Scadding GK. Perennial rhinitis in the under 4s: a difficult problem to treat safely and effectively? A comparison of intranasal fluticasone propionate and ketotifen in the treatment of 2-4-year-old children with perennial rhinitis. Pediatr Allergy Immunol 2004; 15: 261–6. |
|
30. |
Di Lorenzo G, Pacor ML, Pellitteri ME, et al. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. Clin Exp Allergy 2004; 34: 259–67. |
|
31. |
Baena-Cagnani CE. Safety and tolerability of treatments for allergic rhinitis in children. Drug Saf. 2004; 27: 883–98. |
|
32. |
Schenkel EJ, Skoner DP, Bronsky EA, et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics 2000; 105: E22. |
|
33. |
Diepgen TL. for the Early Treatment of the Atopic Child Study Group. Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months. Pediatr Allergy Immunol 2002; 13: 278–86. |
|
34. |
Sheth KK, Cook CK, Philpot EE, et al. Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function. Allergy Asthma Proc 2004; 25: 115–20. |
|
35. |
Joos GF, Brusselle GG, Van Hoecke H, et al. Positioning of glucocorticosteroids in asthma and allergic rhinitis guidelines (versus other therapies).Immunol Allergy Clin North Am 2005; 25: 597–612, vii-viii. |
|
36. |
Daley-Yates PT, Richards DH. Relationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic/pharmacodynamic model. Clin Ther 2004; 26: 1905–19. |
|
37. |
Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database Syst Rev 2003, Issue 4. |
|
38. |
Wilson DR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005; 60: 4–12. |
|
39. |
Durham SR, Walker SM, Varga EM, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341: 468–75. |
|
40. |
Nettis E. Systemic reactions to allergen immunotherapy: a review of the literature. Immunopharmacol Immunotoxicol 2003; 25: 1–11. |
|
41. |
Borchers AT, Keen CL, Gershwin ME. Fatalities following allergen immunotherapy. Clin Rev Allergy Immunol. 2004; 27: 147–58. |
|
42. |
Berger WE. Treatment of allergic rhinitis and other immunoglobulin E-mediated diseases with anti-immunoglobulin E antibody. Allergy Asthma Proc 2006; 27(2 Suppl 1): S29–32. |
|
43. |
Walls RS, Heddle RJ, Tang MLK , et al. Optimising the management of allergic rhinitis: an Australian perspective. Med J Aust 2005; 182: 28–33. |
|
44. |
Graft D, Aaronson D, Chervinsky P, et al. A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray. J Allergy Clin Immunol 1996; 98: 724–31. |
